Tiger Brokers

Top7 x 24

Moderna’s Gain Widens To 150%, MRK Rises More Than 12%, BioNTech Climbs Over 24%

Tiger Newspress·2026/08/19
Moderna’s Gain Widens To 150%, MRK Rises More Than 12%, BioNTech Climbs Over 24%

U.S. Stocks Open Higher; Nasdaq Gains 0.3%, MRNA Surges 90%, Marvell Rises over 10%, SK Hynix Climbs 5%

Tiger Newspress·2026/08/19
U.S. Stocks Open Higher; Nasdaq Gains 0.3%, MRNA Surges 90%, Marvell Rises over 10%, SK Hynix Climbs 5%

Spot Gold Up 3% Intraday, Hitting a New High Since June 5

MT Newswires Live·2026/08/19
Spot Gold Up 3% Intraday, Hitting a New High Since June 5

U.S. Long Yields Retreat as Bond Sell-off Eases

Tiger Newspress·2026/08/19
U.S. Long Yields Retreat as Bond Sell-off Eases

Marvell Issues Warrants To Google, Cementing Custom-Chip Partnership Agreement

Options & Short Sell·2026/08/19
Marvell Issues Warrants To Google, Cementing Custom-Chip Partnership Agreement

Micron Just Crushed NAND Flash Expectations — Is The AI Memory Boom Still Accelerating?

Bellwether Stocks Movement·2026/08/19
Micron Just Crushed NAND Flash Expectations — Is The AI Memory Boom Still Accelerating?

Nebius To Raise $4.5B Via Convertible Notes To Fund Data-Center And GPU Expansion

Bellwether Stocks Movement·2026/08/19
Nebius To Raise $4.5B Via Convertible Notes To Fund Data-Center And GPU Expansion

Pre-Bell | Nasdaq Futures Edge Lower; YJ Surges Nearly 150%, Moderna Gains More Than 80%, SK Hynix Rises over 4%

Tiger Newspress·2026/08/19
Pre-Bell | Nasdaq Futures Edge Lower; YJ Surges Nearly 150%, Moderna Gains More Than 80%, SK Hynix Rises over 4%

The "Holy Grail" Of Cancer Treatment? Moderna's Melanoma MRNA Vaccine Succeeds In Phase 3 Trial

Options & Short Sell·2026/08/19
The "Holy Grail" Of Cancer Treatment? Moderna's Melanoma MRNA Vaccine Succeeds In Phase 3 Trial
More

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10